HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US COVID-19 Fraud: Oleander Stops Viral Duplication, Oral Rinse Delivers 30-Second Cure

Executive Summary

Online claims and social media posts lead to warnings to Phoenix Biotechnology and Avila Herbals for claiming oleander homeopathic at 4X concentration can interfere with COVID-19 and other viruses’ duplication, and Rowpar Pharmaceuticals about a rapid cure provided by oral rinses and spray.

You may also be interested in...

Herbal Sprays, Nasal Swabs Latest Additions On List Of Fraudulent COVID Cures Offered In US

“Germaphobe’s Delight Spray” was “re-vamped … to better meet the challenges of COVID-19,” Fopo Jordan’s Crossing Herbal claimed. Halodine LLC claimed its nasal sanitizer “kills SARS-CoV-2 (the virus that causes COVID-19) in less than 15 seconds.”

US Agencies Warn Company Claiming Electromagnetic Nanoparticles ‘Eradicate’ COVID-19 Virus

Dallas-based Indigenous Products, which suggested online that its nebulizer-delivered electromagnetic silver nanoparticles could “eradicate” the novel coronavirus, is among the latest recipients of warning letters from the US FDA and/or FTC to firms making COVID-19 claims.

After US FDA Finds ‘Particularly Concerning’ GMP Problems, Homeopathic Firm Continues OTC Sales

A warning letter submitted by FDA Office of Regulatory Affairs’ Division of Pharmaceutical Quality Operations I in New Jersey notes that Homeocare Laboratories indicated to agency officials that it no longer is manufacturing OTC drugs.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts